Product Information |
|
Registration Number |
DR-XY35505
|
Generic Name |
Clevudine
|
Brand Name |
Revovir
|
Dosage Strength |
30 mg
|
Dosage Form |
Capsule
|
Classification |
Prescription Drug (RX)
|
Packaging |
HDPE bottle of 30 capsules with desiccant
|
Pharmacologic Category |
Antiviral [Nucleoside/Nucleotide
Transcriptase Inhibitor]
|
Manufacturer |
Bukwang Pharm. Co., Ltd.
|
Country of Origin |
Korea
|
Trader |
|
Importer |
HI-Eisai Pharmaceutical, Inc.
|
Distributor |
Zuellig Pharma Corporation
|
Application Type |
Initial [from Monitored Release]
|
Issuance Date |
30 May 2022
|
Expiry Date |
07 March 2026
|